Show simple item record

dc.creatorKaiser, Jocelynen
dc.date.accessioned2011-07-12T18:21:34Zen
dc.date.available2011-07-12T18:21:34Zen
dc.date.created2008-05-02en
dc.date.issued2008-05-02en
dc.identifierhttp://www.sciencemag.orgen
dc.identifier.bibliographicCitationScience 2008 May 2; 320(5876): 606-607en
dc.identifier.urihttp://hdl.handle.net/10822/512916en
dc.descriptionnewsen
dc.formatArticleen
dc.languageengen
dc.source316491en
dc.subjectAdultsen
dc.subjectChildrenen
dc.subjectDiseaseen
dc.subjectGene Therapyen
dc.subjectResearchersen
dc.subject.classificationGene Therapy / Gene Transferen
dc.subject.classificationResearch on Special Populationsen
dc.subject.classificationResearch on Newborns and Minorsen
dc.titleTwo teams report progress in reversing loss of sight. The first safety trials of gene therapy for a degenerative eye disease produced good results in adults; researchers now intend to treat children.en
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885